In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

Health Secretary Robert F. Kennedy Jr. announced Tuesday that the federal government is canceling nearly $500 million in funding for the development of mRNA vaccines, a revolutionary new technology ...

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

This includes terminating awards and contracts with pharmaceutical companies and universities and canceling 22 investment ...

Adams warns cutting funding for mRNA vaccine research will cost lives, derail medical progress, and give China an advantage.